Analyst stock forecast
Innoviva Forecast: $35.00 Analyst Target
Direct answer
Innoviva's average price target is $35.00.
The target implies +65.8% from the recorded current price, and the consensus rating is Buy.
The low target implies -14.7%, the high target implies +117.9%, and the range spans 132.6% of the current price.
Forecast evidence checked September 30, 2026.
Get free Innoviva email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $21.11
- Average price target
- $35.00
- High price target
- $46.00
- Low price target
- $18.00
- Low target gap
- -14.7%
- Target upside
- +65.8%
- High target gap
- +117.9%
- Target range width
- 132.6%
- Consensus rating
- Buy
- Analysts
- 5
- Evidence date
- September 30, 2026
- Valid through
- October 7, 2026
Explore related company data
Read the frequently asked questions.
What is Innoviva's average price target?
Innoviva's verified average price target is $35.00. The target range is $18.00 to $46.00.
How far are Innoviva's low and high targets from the recorded price?
The low target implies -14.7%, while the high target implies +117.9%.
How many analysts are included in Innoviva's consensus?
The verified consensus includes 5 analysts.
How is Innoviva's target upside or downside calculated?
The average target of $35.00 is divided by the recorded price of $21.11, then one is subtracted to produce +65.8%. This does not guarantee a future return.
When was Innoviva's analyst forecast verified?
The data was verified on 2026-09-30. The dataset is valid through 2026-10-07.